The most active researchers, institutions, and subtopics in Sickle Cell Disease, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 594 recent PubMed papers (2021-2026) matching "sickle cell disease gene therapy". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Sharma Akshay | St. Jude Children's Research Hospital | 31 |
| 2 | Makani Julie | Muhimbili University of Health and Allied Sciences | 13 |
| 3 | Miccio Annarita | Université Paris Cité | 12 |
| 4 | Krishnamurti Lakshmanan | Yale University School of Medicine | 11 |
| 5 | Frangoul Haydar | Sarah Cannon Research Institute | 11 |
| 6 | Leonard Alexis | St. Jude Children's Research Hospital | 10 |
| 7 | Kanter Julie | University of Alabama at Birmingham | 9 |
| 8 | Locatelli Franco | IRCCS Bambino Gesù Children's Hospital | 8 |
| 9 | Chalumeau Anne | Université Paris Cité | 7 |
| 10 | Antoniou Panagiotis | AstraZeneca | 6 |
| 11 | Corbacioglu Selim | University of Regensburg | 5 |
| 12 | Abraham Allistair | Children's National Hospital | 5 |
| 13 | Eapen Mary | Medical College of Wisconsin | 5 |
| 14 | Johnson Liza-Marie | St. Jude Children's Research Hospital | 5 |
| 15 | Malik Punam | Cincinnati Children's Hospital Medical Center | 5 |
| 16 | Bhatia Monica | Columbia University/New York-Presbyterian Morgan Stanley C | 5 |
| 17 | Nkya Siana | Muhimbili University of Health and Allied Sciences | 5 |
| 18 | Bhoopalan Senthil Velan | St. Jude Children's Research Hospital | 5 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
The future of pediatric gene therapy: CRISPR-Cas9, AI, and personalized medicine. (2026) · PMID 42469418
Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for can (2026) · PMID 42462791
CRISPR/Cas9-Based Genome Editing: Understanding Differences in DNA Repair Pathways, Profiles, and Outcomes. (2026) · PMID 42450173
Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies. (2026) · PMID 42448320
Blood Rheology After Allogeneic Hematopoietic Stem Cell Transplantation or Gene Therapy in Sickle Cell Disease. (2026) · PMID 42448317
A full Sickle Cell Disease brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.